Trial intelligence / Profile preview

Pertussis memory immunity and preadolescent acellular booster study in 9-year-old children

2013-001864-50Phase 4Completed

Sponsor
National Institute for Public Health and the Environment
Start
May 2013
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 4 trial of Boostrix Polio in pertussis (2 arms), sponsored by National Institute for Public Health and the Environment. Primary endpoint: Pertussis-specific immune response before and after booster vaccination. Started May 2013; status: completed.

02

Drugs

Boostrix Polio
03

Conditions

pertussis

Beyond the preview

Go deeper on 2013-001864-50.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-001864-50.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call